Target Modulation by a Kinase Inhibitor Engineered to Induce a Tandem Blockade of the Epidermal Growth Factor Receptor (EGFR) and c-Src: The Concept of Type III Combi-Targeting
Suman Rao(Royal Victoria Hospital), Bertrand J. Jean‐Claude(Royal Victoria Regional Health Centre)
Cited by 25
Related Papers
Quantitative Analysis of the Potency of Equimolar Two-Drug Combinations and Combi-Molecules Involving Kinase Inhibitors In Vitro: The Concept of Balanced Targeting
|International Journal of Molecular Sciences|2021|2